Akèy › Kansè Vezik ki pa envazif miskilè › Illinois › Cicero
Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Cicero, IL
5 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan ak bò kote Cicero (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Ap rekriteFaz 3
- Loyola University Medical Center, Maywood · 5 mi lwen
- Marjorie Weinberg Cancer Center at Loyola-Gottlieb, Melrose Park · 7 mi lwen
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Ap rekriteFaz 2
- Associated Urological Specialists - Chicago Ridge ( Site 0139), Chicago Ridge · 10 mi lwen
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ap rekriteFaz 2
- Associated Urological Specialists, Chicago Ridge · 10 mi lwen
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Ap rekriteFaz 3
- Associated Urological Specialists, Chicago Ridge · 10 mi lwen
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
Ap rekriteEtid obsèvasyon
- Associated Urological Specialists, Chicago Ridge · 10 mi lwen
Etid Kansè Vezik ki pa envazif miskilè nan lòt vil
- Columbus, OH10 etid
- Dallas, TX10 etid
- New York City, NY10 etid
- Myrtle Beach, SC9 etid
- Edison, NJ9 etid
- Baltimore, MD8 etid
- Syracuse, NY8 etid
- Nashville, TN8 etid
- Houston, TX7 etid
- Indianapolis, IN7 etid
- Philadelphia, PA7 etid
- Birmingham, AL7 etid
Lòt etid nan Cicero
- Kansè Poumon ki pa ti selil24 etid
- Kansè poumon17 etid
- Kansè pwostat14 etid
- Kansè (tout kalite)13 etid
- Kansè nan tete11 etid
- Leksemi mieloïd egi11 etid
- Kansè kolorektal10 etid
- Kansè vejik8 etid
- Melanom7 etid
- Maladi kadyovaskilè7 etid
- Kansè Metastatik7 etid
- Myelom Miltip6 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.